Hospital-Acquired Disease Testing Market
- 2026 年市場規模
- USD 18.6 Bn
- 2033 年預估規模
- USD 49.4 Bn
- 年複合成長率 CAGR
- 15.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Hospital-Acquired Disease Testing Market, By Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia Stents, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus (MRSA), and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is a major factor driving the growth of the hospital-acquired disease testing market. Devices such as catheters and ventilators that are used in modern care facilities are also among the primary causes of these infections.
Market Dynamics
Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships in order to expand their product portfolio and global presence in the hospital-acquired disease testing market. For instance, in April 2019, Meridian Bioscience, Inc. entered an agreement to acquire GenePOC Inc., a Canada based provider of molecular diagnostic instruments and assays. Through this acquisition, Meridian Bioscience will include state-of-the art revogene molecular diagnostics platform of GenePOC Inc. in its diagnostics portfolio.
Key features of the study
• This report provides in-depth analysis of the global hospital-acquired disease testing market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Luminex Corporation, Diatherix laboratories, Life technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomerieux, and Cepheid.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product Type up-gradation, market expansion, and marketing tactics
• The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital-acquired disease testing market
Market Segmentation
• By Test Type
o Urinary Tract Infection
o Surgical Site Infection
o Pneumonia Stents
o Blood Stream Infection
o Methicillin-resistant Staphylococcus Aureus (MRSA)
o Others
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Luminex Corporation
o Diatherix Laboratories
o Life Technologies
o Cantel Medical Corporation
o Meridian Biosciences Inc
o Nordion Inc
o Qiagen GmbH
o Hoffmann-La Roche Ltd.
o Biomerieux
o Cepheid
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Test Type
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Hospital-Acquired Disease Testing Market, By Test Type, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026– 2033
Segment Trends
o Urinary Tract Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Surgical Site Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Pneumonia Stents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Blood Stream Infection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Methicillin-resistant Staphylococcus Aureus (MRSA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
5. Global Hospital-Acquired Disease Testing Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
6. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Luminex Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Diatherix Laboratories
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Life Technologies
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cantel Medical Corporation
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Meridian Biosciences Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Nordion Inc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Qiagen GmbH
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
F.Hoffmann-La Roche Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Biomerieux
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cepheid
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
7. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們